Alight offers highly asymmetric turnaround upside from recurring enterprise benefits infrastructure, but leverage, client losses, and execution risk make the stock a speculative recovery investment.
Overview
Alight is a technology-enabled benefits and human-capital administrator whose Alight Worklife platform connects employers, employees, and benefit providers. Its Health, Wealth, and Leave Solutions generate primarily recurring PMPM, asset-based, and participant-based fees under multiyear contracts; recurring revenue represents 92.2% of the mix. The company serves a dominant share of the Fortune 100, supports more than 30 million lives, and manages $1.7 trillion in wealth assets, creating meaningful switching costs and operational scale. Financially, the turnaround is still incomplete: Q2 2026 revenue declined 3.2% year over year to $511 million, adjusted EBITDA fell to $92 million with an 18.0% margin, and adjusted diluted EPS of $0.91 beat consensus by 31.9%. Full-year revenue guidance was reduced to $2.078–$2.098 billion and EBITDA to $400–$415 million. **The valuation opportunity depends on margin recovery and deleveraging**, not near-term revenue growth. AI modernization targets 300–600 basis points of EBITDA-margin expansion toward 28%, while the $1.2 billion Strada divestiture and free cash flow can support debt reduction. The principal near-term catalysts are service insourcing, contract stabilization, improving organic growth from 2027–28, and refinancing progress before 2028.